Jehovah’s Witnesses have announced a significant change to their longstanding prohibition on blood transfusions, allowing members to accept certain blood components derived from donated blood. The update, issued by the sect’s governing body, permits followers to choose whether to receive treatments involving red blood cells, white blood cells, plasma, and platelets. However, the ban on transfusions of whole blood remains in place, based on the group’s interpretation of biblical scripture.

The policy shift is regarded by medical professionals as a crucial development for patient safety. Dominic Wilkinson, a professor of medical ethics at Oxford University, described the decision as one that “significantly reduces the dilemma for both parents and health professionals.” The revision could lead to improved treatment options for Jehovah’s Witnesses, who have historically declined blood transfusions due to religious beliefs.

In the United Kingdom, there are an estimated 144,000 Jehovah’s Witnesses. Campaigners have pointed to approximately 1,200 excess deaths annually linked to the refusal of blood transfusions among members of the faith. The new guidelines could potentially reduce these numbers by expanding acceptance of certain blood products that are critical in managing various medical conditions.

Despite this shift, the organization maintains its position against transfusions of whole blood, citing a theological interpretation of Acts 15:20. This scriptural reference has historically underpinned the group’s strict prohibitions relating to blood.

The governing body’s update reflects an evolving approach to balancing religious doctrine with advances in medical care. It gives individual members greater autonomy to make decisions regarding their treatment, while the leadership retains clear boundaries aligned with their interpretation of biblical teachings.